SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending as investors anticipate earnings, with the community debating the stock's valuation amid high P/E ratios and a recent surge to all-time highs. Bulls cite the company's AI prospects and government contracts, while bears express concerns about an overextended valuation and potential post-earnings pullback. Discussions also include speculation about a possible stock split and potential partnerships.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending downwards as the community debates the implications of increased AI spending and a recent tax hit. While some investors see a buying opportunity due to the company's strong fundamentals and growth potential, others express concern about unclear returns on AI investments. Community chatter includes speculation about potential partnerships and the possibility of a stock split.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as the community debates whether the recent drop is a buying opportunity or a sign of deeper issues, with some pointing to tariff concerns and overall consumer weakness. Many traders are watching key support levels and potential gap fills, while others express frustration with the stock's performance despite positive earnings and brand recognition. The stock's next move may depend on broader market sentiment and upcoming trade talks.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

TERN is trending as discussions revolve around its potential in the CML treatment landscape after positive data was presented. Some investors are optimistic about TERN-701's prospects, while others express concerns about the risks associated with Phase 1 stocks and potential dilutions. Amidst the TERN discussion, some traders are also eyeing ENVB for a potential short squeeze similar to BYND.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Lilly is trending as discussions revolve around its leading position in the weight loss drug market, particularly its competition with Novo Nordisk. Community members are weighing in on the potential impacts of government negotiations on drug pricing, while also eyeing the company's pipeline and potential growth catalysts. Bullish sentiment is fueled by strong sales and raised price targets.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is trending as traders discuss its potential for a ZEC-like surge, with some highlighting its limited supply and comparing its potential to Bitcoin. Community members are actively speculating on price targets and whether DASH will benefit from renewed interest in privacy coins. There's also discussion about DASH's utility and integration with platforms like DoorDash.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

ENVB is trending as retail traders discuss its potential for a short squeeze, drawing comparisons to past squeezes like $BYND and $AMC. The community is focused on its low float and recent news, with some anticipating a significant price increase. Some traders are also discussing a reverse split.

Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through the following segments: North America, International Personal Care, and International Family Care and Personal. The North America segment consists of products encompassing each of daily-need categories across consumer and professional channels including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. The International Personal Care segment consists of three core categories: Baby & Child Care, Adult Care, and Feminine Care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. The International Family Care and Professional segment consists of two core categories: Family Care and Professional, including facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Irving, TX.

Kimberly-Clark Corp.

Kimberly-Clark ($KMB) is trending following news of a $48.7 billion bid to acquire Kenvue ($KVUE), owner of brands like Tylenol and Band-Aid, in a cash-and-stock deal, though some investors express concerns about the debt load and potential dividend impact. The community is discussing merger arbitrage opportunities in $KVUE, potential stock dilution for $KMB, and the CEO's upcoming appearance on CNBC's Mad Money amid share weakness. Others believe that the Tylenol controversy is overblown, and that $KMB is a good long term investment.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to a significant stock drop following the FDA's revised stance on clinical trial data for its Huntington's disease therapy, leading to uncertainty about future approvals. The community is debating the validity of the FDA's concerns, potential for a lawsuit, and if the stock is now a buying opportunity. Discussions also include potential political interference and comparisons to other biotech firms facing regulatory hurdles.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

SGML is seeing volatile trading as investors react to recent price swings and debate the company's future prospects within the lithium sector. Community discussions revolve around whether the dip represents a buying opportunity or signals deeper issues, with some citing rumors of altered production plans. Despite broader optimism for lithium and its role in electric vehicles, SGML faces questions about its relative performance compared to peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Peter

Jack

Sullivan

henry tingle

StockTwits Web

EPWK Holdings Ltd

@sullivan1  
based on any fact? 
i certainly hope it is so, but do not see any news

  
based on any fact? 
i certainly hope it is so, but do not see any news